Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:JNJ)

Shockwave Medical Reports First Quarter 2024 Financial Results

GlobeNewswire 1 day ago

Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual "Prepackaged" Reorganization

Business Wire 6 days ago

Johnson & Johnson to Participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC)

Business Wire April 22, 2024

Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%

Business Wire April 16, 2024

Johnson & Johnson Reports Q1 2024 Results

Business Wire April 16, 2024

Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

Business Wire April 8, 2024

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy

PR Newswire April 5, 2024

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.

PR Newswire April 5, 2024

Johnson & Johnson to Acquire Shockwave Medical

Business Wire April 5, 2024
View More News ››

Opinion & Analysis (NYSE:JNJ)

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016

What Andy Grove and Michael Milken have taught us about prostate cancer

The Life Sciences Report April 20, 2016

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton October 15, 2015

Bearish On Bucks? Try This ETF

Benzinga.com  September 18, 2015

Eight iconic American companies that have been hurt by the strong dollar

Stockhouse Editorial September 10, 2015
View More Opinion ››

Bullboard Posts (NYSE:JNJ)

Will this ever turn around?

EOM.
BSdetector2016 - April 5, 2024

RE:A BIG DAY for us

looks like like S&P could turn around and help J&J 
TechTitan - October 6, 2023

A BIG DAY for us

Earnings report for us today.
StockAlchemy - July 20, 2023

Starting slow

Jumped in on this a while back and so far the decision to hold is one I don't regret.
scottrose - July 6, 2023

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Richardson35 - April 13, 2023

Aveeno

Until recently Aveeno daily moisturizing lotion  was using Canadian oats. They no longer mention Canadian oats on their bottle. I...
jimsenior - January 23, 2023
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »